Página 50 - v24n1

9. Garg S, Messenger AG. Alopecia areata: Evidence-Based treat-
ments. Semin Cutan Med Surg 2009; 28: 15-8.
10. Price VH. Treatment of hair loss. New Eng J Med 1999; 341:
964-73.
11. Freyschmidt-Paul P, McElwee K, Hoffmann R. Alopecia areata.
En: Hertl M, ed. Autoimmune diseases of the skin. Pathogenesis,
diagnosis, management. Viena. Springer Ed, 2007; 341-54.
12. Freyschmidt-Paul P,, Hoffmann R, McElwee K. Alopecia areata.
En: Blume-Peytavi U, Tosti A, Whiting D, Trüeb R, eds. Hair growth
and disorders. Viena. Springer Ed, 2008; 311-32.
13. Alkhalifah A, Alsantali A, Wang E, McElwee KJ, Shapiro J. Alopecia
areata update. Part II. Treatment. J Am Acad Dermatol 2010; 62:
191-202.
14. Morales-Sánchez MA, Domínguez-Gómez MA, Jurado-Santa
Cruz F, Peralta-Pedrero ML. Inmunizaciones y bacterias patóge-
nas en la faringe como factores de riesgo para alopecia areata.
Actas Dermosifiliogr 2010; 101: 437-43.
15. García-Hernández MJ, Camacho F. Tratamiento de la alopecia
areata: estado actual. Piel 2002; 17: 214-7.
16. Pascher F, Kurtin S, Andrade R. Assay of 0.2% fluocinolone ace-
tonide cream for alopecia areata and totalis. Dermatológica
1970: 141: 193-202.
17. Leyden JJ, Kligman AM. (1972) Treatment of alopecia areata
with steroid solution. Arch Dermatol 1972; 106: 924.
18. Charuwichitratana S, Wattanakrai P, Tanrattanakorn S (2000)
Randomized double-blind placebo-controlled trial in the treat-
ment of alopecia areata with 0.25% desoximetasone cream.
Arch Dermatol 2000; 136: 1276-7.
19. Lehnert W Zur Lokalbehandlung schwerer Formen der Alopecia
areata mit Kortikosteroidsalbe. Dermatol Monatsschr 1974;
160: 396-8.
20. Tosti A, Piraccini BM, Pazzaglia M, Vincenzi C. Clobetasol
propionate 0.05% under occlusion in the treatment of alopecia
totalis/universalis. J Am Acad Dermatol 2003; 49: 96-8.
21. Tosti A, Iorizzo M, Botta GL et al. Efficacy and safety of a new
clobetasol propionate 0.05% foam in alopecia areata: A
randomized, double-blind placebo-controlled trial. J Eur Acad
Dermatol Venereol 2006; 20: 1243-7.
22. Mancuso G, Balducci A, Casado C et al. Efficacy of betametha-
sone valerato foam formulation in comparison with betametha-
sone dipropionate lotion in the treatment of mild-to-moderate
alopecia areata. A mjulticenter, prospective, ramdomized , con-
trolled, investigator-blinded trial. Int J Dematol 2003; 42: 572-5.
23. Freyschmidt-Paul P, McElwee K, Hoffmann R. Alopecia areata.
En: Hertl M, ed. Autoimmune diseases of the skin. Pathogenesis,
diagnosis, management. Viena. Springer Ed., 2007; 341-54.
23. Camacho F, García-Hernández MJ. Zinc aspartate, biotin, and clo-
betasol propionate in the treatment of alopecia areata in child-
hood. Pediatr Dermatol 1999; 16: 336-8.
24. Kumaresan M. Intralesional steroids for alopecia areata. Int J
Trichol 2010; 2: 63-5.
25. Porter D, Burton JL. A comparison of intra-lesional triamcinolone
hexacetonide and triamcinolone acetonide in alopecia areata. Br
J Dermatol 1971; 85: 272.
26. Kubeyinje EP. Intralesional triamcinolone acetonide in alopecia
areata amongst 62 Saudi Arabs. East Afr Med J 1994; 71: 674-5.
27. Coronel-Pérez IM, Rodríguez-Rey EM, Camacho-Martínez FM.
Latanoprost in the treatment of eyelash alopecia in alopecia areata
universalis. J Eur Acad Dermatol Venereol 2010; 24: 481-4.
28. Dillaha CJ, Rothman S. Therapeutic experiments in alopecia
areata with orally administered cortisone. J Am Med Ass 1952;
150: 546-50.
29. Sharma VK. Pulsed administration of corticosteroids in the treat-
ment of alopecia areata. Int J Dermatol 1996; 35: 133-6.
30. Sharma VK, Muralidhar S. Treatment of widespread alopecia
areata in young patients with monthly oral corticosteroid pulse.
Pediatr Dermatol 1998; 15: 313-7.
31. Seiter S, Ugurel S, Tilgen W, Reinhold U. High-Dose pulse corti-
costeroid therapy in the treatment of severe alopecia areata.
Dermatology 2001; 202: 230-4.
32. Schulz A, Hamm H, Weiglein U, Axt M, Bröcker EB. Dexametha-
sone pulse therapy in severe long-standing alopecia areata: a
treatment failure. Eur J Dermatol 1996; 6: 26-9.
33. Kar BR, Handa S, Dogra S, Kumar B. Placebo-controlled oral
pulse prednisolone therapy in alopecia areata. J Am Acad Der-
matol 2005; 52: 287-90.
34. Ait Ourhroui M, Hassam B, Khoudri I. Traitement de la pelade par
bolus oral mensuel de prednisone. Ann Dermatol Vénéréol
2010; 137: 514-8.
35. Sharma VK, Gupta S. Twice weekly 5 mg dexamethasone oral
pulse in the treatment of extensive alopecia areata. J Dermatol
1999; 26: 562-5.
36. Happle R, Hausen BM, Wiesner-Menzel L. Diphencyprone in the
treatment of alopecia areata. Acta DermVenereol 1983; 63: 49-52.
37. Happle R: Antigenic competition as a therapeutic concept for
alopecia areata. Arch Dermatol Res 1980; 267: 109-14.
38. Herbst V, Zoller M, Kissling S et al. Diphenylcyclopropenone
treatment of alopecia areata induces apoptosis of perifollicular
lymphocytes. Eur J Dermatol 2006; 16: 537-42.
39. Hoffmann R, Wenzel E, Huth A et al. Cytokine mRNA levels in
alopecia areata before and after treatment with the contact all-
ergen diphenylcyclopropenone. J Invest Dermatol 1994; 103:
530-3.
40. Behrens-Williams SC, Leiter U, Schiener R, Weidmann M, Peter
RU, Kerscher M. The PUVA-turban as a new option of applying a
dilute psoralen solution selectively to the scalp of patients with
alopecia areata. J Am Acad Dermatol 2001; 44: 248-52.
41. Monfrecola G, D’Anna F, Delfino M. Topical hematoporphyrin
plus UVA for the treatment of alopecia areata. Photodermatolo-
gy 1987; 4: 305-6.
42. Bissonnette R, Shapiro J, Zeng H, McLean DI, Lui H. Topical pho-
todynamic therapy with 5-aminolaevulinic acid does not induce
hair regrowth in patients with extensive alopecia areata. Br J Der-
matol 2000; 143: 1032-5.
43. Zakaria W, Passeron T, Ostovari N, Lacour JP, Ortonne JP. 308-nm
excimer laser therapy in alopecia areata. J Am Acad Dermatol
2004; 51: 837-8.
44. Ohtsuki A, Hasegawa T, Ikeda S. Treatment of alopecia areata
with 308-nm excimer lamp. J Dermatol 2010; 37: 1032-5.
45. Price VH, Double-blind placebo-controlled evaluation of topical
minoxidil in extensive alopecia areata. J Am Acad Dermatol
1987; 16: 730-6.
46. Fiedler-Weiss VC. Topical minoxidil solution (1% and 5%) in the
treatment of alopecia areata. J Am Acad Dermatol 1987; 16:
745-8.
47. Camacho F, Moreno JC, García-Hernandez MJ. Telogen alopecia
from UV rays. Arch Dermatol 1996; 132: 1398-9.
48. Nelson DA, Spielvogel RL. Anthralin therapy for alopecia areata.
Int J Dermatol 1985; 24: 606-7.
49. Fiedler-Weiss VC, Buys CM. Evaluation of anthralin in the treat-
ment of alopecia areata. Arch Dermatol 1987; 123: 1491-3.
50. Torchia D, Schachner LA. Bilateral treatment for alopecia areata.
Pediatr Dermatol 2010; 27: 415-6.
51. Shapiro J, Lui H, Tron V et al. Systemic cyclosporine and low-dose
prednisone in the treatment of chronic severe alopecia areata: a
clinical and immunopathologic evaluation. J Am Acad Dermatol
1997; 36: 114-7.
52. Ferrando J, Grimalt R. Partial response of severe alopecia areata
to cyclosporine A. Dermatology 1999; 199: 67-9.
53. Wiseman MC, Shapiro J. Therapeutic approach to alopecia
areata. J Cut Med Surg 1999; 3 (Suppl. 3): S31-S35.
54. García Hernández MJ, Camacho Martínez F. Novedades en el tra-
tamiento de la alopecia areata y androgenética. Monogr Derma-
tol 2004; 17:49-59.
volumen 24 • nº 1 • enero-febrero 2011 47